Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ROE

The ROE as of October 2026 (TTM) for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) is 2.43%

According to Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 2.43%. This represents a change of 356.56% compared to the average of 0.53% of the last 4 quarters.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) Historical ROE (quarterly & annually)

How has 6990.HK ROE performed in the past?

The mean historical ROE of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. over the last ten years is 1.13%. The current 2.43% ROE has changed 114.89% with respect to the historical average. Over the past ten years (40 quarters), 6990.HK's ROE was at its highest in in the December 2021 quarter at 7.10%. The ROE was at its lowest in in the December 2023 quarter at -12.82%.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) Average ROE

How has 6990.HK ROE performed in the past?

The current ROE of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) ROE vs. Peers

How is 6990.HK’s ROE compared to its peers?

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.’s ROE is less than Innovent Biologics, Inc. (6.06%), greater than Zai Lab Limited (-27.40%), less than HUTCHMED (China) Limited (1.43%), less than InnoCare Pharma Limited (12.35%), greater than CStone Pharmaceuticals (-43.54%), greater than Akeso, Inc. (-10.86%), less than Antengene Corporation Limited (6.51%), greater than TYK Medicines, Inc (-77.60%), less than GenFleet Therapeutics (Shanghai) Inc. (0%), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-32.32%),

Build a custom stock screener for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.